Holen Sie sich die Stockscreener-App
1.07
5.94%
0.06
Schlusskurs vom Vortag:
$1.01
Offen:
$1.01
24-Stunden-Volumen:
633.02K
Relative Volume:
0.71
Marktkapitalisierung:
$51.94M
Einnahmen:
$19.94M
Nettoeinkommen (Verlust:
$-37.37M
KGV:
-1.0288
EPS:
-1.04
Netto-Cashflow:
$-33.38M
1W Leistung:
+16.57%
1M Leistung:
-7.76%
6M Leistung:
-19.55%
1J Leistung:
-42.47%
1-Tages-Spanne:
$0.96
$1.11
1-Wochen-Bereich:
$0.92
$1.11
52-Wochen-Spanne:
$0.595
$2.38
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Firmenname
Werewolf Therapeutics Inc
Sektor
Branche
Telefon
617-952-0555
Adresse
200 TALCOTT AVENUE, WATERTOWN
Vergleichen Sie HOWL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
1.07 | 49.03M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-08-24 | Eingeleitet | Wedbush | Outperform |
| 2023-06-06 | Fortgesetzt | Jefferies | Buy |
| 2021-09-10 | Eingeleitet | BofA Securities | Buy |
| 2021-05-25 | Eingeleitet | Evercore ISI | Outperform |
| 2021-05-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-05-25 | Eingeleitet | Jefferies | Buy |
| 2021-05-25 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Werewolf Therapeutics Inc Aktie (HOWL) Neueste Nachrichten
IPO Launch: What is the fair value of Werewolf Therapeutics Inc stock nowWeekly Investment Report & Momentum Based Trading Signals - BỘ NỘI VỤ
How Werewolf Therapeutics Inc. stock benefits from global expansionEarnings Summary Report & Expert Curated Trade Setup Alerts - Newser
What is the fair value of Werewolf Therapeutics Inc. stock nowStop Loss & Daily Profit Maximizing Tips - Newser
Werewolf Therapeutics (HOWL) former 10% owners sell $183k in stock - Investing.com Canada
MPM BioVentures sells Werewolf Therapeutics (HOWL) stock for $183k - Investing.com India
MPM BioVentures sells Werewolf Therapeutics (HOWL) stock for $183k By Investing.com - Investing.com South Africa
Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $117k - Investing.com
A new trading data show Werewolf Therapeutics Inc (HOWL) is showing positive returns. - Setenews
Will Werewolf Therapeutics Inc. stock benefit from green energy trends - Newser
Aug Mood: Is Werewolf Therapeutics Inc. stock ready for breakoutWeekly Trade Recap & Daily Technical Stock Forecast Reports - moha.gov.vn
Why retail investors pile into Werewolf Therapeutics Inc. stockBreakout Watch & Verified Momentum Watchlists - BỘ NỘI VỤ
Werewolf Therapeutics (HOWL) 10% owners sell $179k in stock By Investing.com - Investing.com Australia
Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $115k By Investing.com - Investing.com Australia
MPM BioVentures sells Werewolf Therapeutics (HOWL) shares for $179k By Investing.com - Investing.com Australia
Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $115k - Investing.com
MPM BioVentures sells Werewolf Therapeutics (HOWL) shares for $179k - Investing.com
Werewolf Therapeutics (HOWL) 10% owners sell $179k in stock - Investing.com India
A Look at Werewolf Therapeutics Inc (HOWL) Shares in the Recent Past Indicates Growth - Setenews
Head-To-Head Contrast: Werewolf Therapeutics (NASDAQ:HOWL) versus X4 Pharmaceuticals (NASDAQ:XFOR) - Defense World
Werewolf Therapeutics (HOWL) 10% owner sells $147,912 in stock By Investing.com - Investing.com India
Werewolf Therapeutics (HOWL) 10% owner sells $147,912 in stock - Investing.com
Chmn Evnin Sells 102,753 ($94.9K) Of Werewolf Therapeutics Inc [HOWL] - TradingView
[Form 4] Werewolf Therapeutics, Inc. Insider Trading Activity - Stock Titan
Predicting Werewolf Therapeutics Inc. trend using moving averagesJuly 2025 Chart Watch & Weekly Watchlist for Hot Stocks - newser.com
Werewolf Therapeutics Inc. stock trend forecastEarnings Trend Report & Low Risk Entry Point Tips - newser.com
Werewolf Therapeutics (NASDAQ:HOWL) Price Target Cut to $7.00 by Analysts at Bank of America - Defense World
What MACD signals say about Werewolf Therapeutics Inc.Portfolio Performance Report & High Return Trade Guides - newser.com
B of A Securities Maintains Werewolf Therapeutics (HOWL) Buy Recommendation - Nasdaq
Werewolf therapeutics (HOWL) sees $200k+ in sales by MPM related entities - Investing.com South Africa
Evnin Luke sells Werewolf Therapeutics (HOWL) shares worth $128k - Investing.com UK
Evnin Luke sells Werewolf Therapeutics (HOWL) shares worth $128k By Investing.com - Investing.com Nigeria
Mpm Bioventures sells Werewolf Therapeutics (HOWL) stock for $200,665 By Investing.com - Investing.com Nigeria
Owner Gadicke Sells 209,652 ($200.7K) Of Werewolf Therapeutics Inc [HOWL] - TradingView
Owner MPM Asset Management Investors BV2014 LLC Files To Sell 4,479 Of Werewolf Therapeutics Inc [HOWL] - TradingView
Owner MPM Asset Management LLC Files To Sell 20,597 Of Werewolf Therapeutics Inc [HOWL] - TradingView
Views of Wall Street’s Leading Experts on Werewolf Therapeutics Inc - Setenews
Will Werewolf Therapeutics Inc. price bounce be sustainableRisk Management & Free Community Consensus Stock Picks - newser.com
How Werewolf Therapeutics Inc. stock performs after earningsSwing Trade & Daily Price Action Insights - newser.com
Why Werewolf Therapeutics Inc. stock is rated strong buyMarket Sentiment Report & Trade Opportunity Analysis Reports - Fundação Cultural do Pará
Finanzdaten der Werewolf Therapeutics Inc-Aktie (HOWL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):